Cargando…

Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined

PURPOSE: To investigate the outcomes of the treatment of keratoconus/corneal ectasia utilizing topographic-guided ablation (WaveLight Contoura) followed by corneal cross-linking. METHODS: Thirty-six eyes of 21 patients were treated for keratoconus/corneal ectasia utilizing topographic guided ablatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Motwani, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214212/
https://www.ncbi.nlm.nih.gov/pubmed/34163129
http://dx.doi.org/10.2147/OPTH.S303559
_version_ 1783710016416514048
author Motwani, Manoj
author_facet Motwani, Manoj
author_sort Motwani, Manoj
collection PubMed
description PURPOSE: To investigate the outcomes of the treatment of keratoconus/corneal ectasia utilizing topographic-guided ablation (WaveLight Contoura) followed by corneal cross-linking. METHODS: Thirty-six eyes of 21 patients were treated for keratoconus/corneal ectasia utilizing topographic guided ablation photorefractive keratectomy (PRK) for treatment of corneal higher-order aberrations and refractive error followed immediately by 15-minute cross-linking were examined retrospectively. Six-month results were analyzed via measurement of vision, refraction, residual higher-order aberrations (HOAs), residual lower-order and higher-order aberrations, as well as for loss or gains of lines of best-corrected visual acuity. RESULTS: All eyes save one had reduction in K1, K2, K Max, K Mean. All eyes had reduction in manifest astigmatism, Contoura-measured astigmatism, higher-order aberrations, higher-order aberrations grouped with lower-order aberrations (Grouped). Four eyes had lost 1–2 lines of vision, mainly to corneal haze formation, 17 eyes gained lines of vision, and 15 eyes equaled their pre-op best-corrected visual acuity. Eight eyes from four sample patients have their data included in this manuscript to demonstrate the procedure and the outcomes. CONCLUSION: Treatment with WaveLight Contoura combined with 15-minute corneal cross-linking is an effective and safe treatment for keratoconus and should be considered a primary treatment to prevent corneal transplant as well as improve vision and corneal irregularity.
format Online
Article
Text
id pubmed-8214212
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82142122021-06-22 Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined Motwani, Manoj Clin Ophthalmol Original Research PURPOSE: To investigate the outcomes of the treatment of keratoconus/corneal ectasia utilizing topographic-guided ablation (WaveLight Contoura) followed by corneal cross-linking. METHODS: Thirty-six eyes of 21 patients were treated for keratoconus/corneal ectasia utilizing topographic guided ablation photorefractive keratectomy (PRK) for treatment of corneal higher-order aberrations and refractive error followed immediately by 15-minute cross-linking were examined retrospectively. Six-month results were analyzed via measurement of vision, refraction, residual higher-order aberrations (HOAs), residual lower-order and higher-order aberrations, as well as for loss or gains of lines of best-corrected visual acuity. RESULTS: All eyes save one had reduction in K1, K2, K Max, K Mean. All eyes had reduction in manifest astigmatism, Contoura-measured astigmatism, higher-order aberrations, higher-order aberrations grouped with lower-order aberrations (Grouped). Four eyes had lost 1–2 lines of vision, mainly to corneal haze formation, 17 eyes gained lines of vision, and 15 eyes equaled their pre-op best-corrected visual acuity. Eight eyes from four sample patients have their data included in this manuscript to demonstrate the procedure and the outcomes. CONCLUSION: Treatment with WaveLight Contoura combined with 15-minute corneal cross-linking is an effective and safe treatment for keratoconus and should be considered a primary treatment to prevent corneal transplant as well as improve vision and corneal irregularity. Dove 2021-06-14 /pmc/articles/PMC8214212/ /pubmed/34163129 http://dx.doi.org/10.2147/OPTH.S303559 Text en © 2021 Motwani. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Motwani, Manoj
Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined
title Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined
title_full Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined
title_fullStr Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined
title_full_unstemmed Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined
title_short Treatment of Keratoconus with WaveLight Contoura and Corneal Cross-Linking Combined
title_sort treatment of keratoconus with wavelight contoura and corneal cross-linking combined
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214212/
https://www.ncbi.nlm.nih.gov/pubmed/34163129
http://dx.doi.org/10.2147/OPTH.S303559
work_keys_str_mv AT motwanimanoj treatmentofkeratoconuswithwavelightcontouraandcornealcrosslinkingcombined